Nonalcoholic Fatty Liver Disease: What Are the Odds Your Patient Will Get a Transplant?

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 8, 2011, Pages 631-632

  Leverage, Scott C ^a   Angulo, Paul ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; PORTAL HYPERTENSION; PROGNOSIS; SCORING SYSTEM; SURGICAL RISK; TREATMENT INDICATION;

FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE;

EID: 79960476318     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.05.018     Document Type: Editorial

References (12)

1. Musso G., Gambino R., Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 2010, 11:430-445.
2. Finucane M.M., Stevens G.A., Cowan M.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
3. Adams L.A., Sanderson S., Lindor K.D., et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005, 42:132-138.
4. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-131.
5. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
6. Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?. Hepatology 2010, 51:373-375. [Erratum in: Hepatology 2010;51:1868.].
7. Xu J., Kochanek K.D., Murphy Sl, et al. Deaths: final data for 2007. Natl Vital Stat Rep 2010, 58:19.
8. Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transplant 2006, 12:523-534.
9. O'Leary J.G., Landaverde C., Jennings L., et al. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. Clin Gastroenterol Hepatol 2011, 9:700-704.
10. Sanyal A.J., Banas C., Sargeant C., et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006, 43:682-689.
11. Ascha M.S., Hanouneh I.A., Lopez R., et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010, 51:1972-1978.
12. Bhala N., Angulo P., van der Poorten D., et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011 Jun 17, [Epub ahead of print].